| Spirig HealthCare AG - Tocilizumab Spirig HC 400 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 69925 | | 03 | | Tocilizumab Spirig HC 400 mg/20 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L04AC07 | | Tocilizumab | | 21.05.2025 | | |
|
| Composition |
| tocilizumabum 400 mg, histidinum, histidini hydrochloridum monohydricum, arginini hydrochloridum, saccharum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 20 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Tocilizumabum | 400mg / 20ml |
| | BAG: Active Agent | Dose |
|---|
| Tocilizumabum | 400 mg |
| | | | Inactive agents |
|---|
| Arginine Hydrochloride | | Histidin Hydrochloride Monohydrate | | Histidine | | Polysorbatum 80 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 011 | | 421.71 | 475.05 | A | SL | No | | 012 | 4 | | | A | | Yes |
|
